We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
-$692M
Cap. Flow %
-0.42%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.05%
2 Technology 7.69%
3 Financials 6.83%
4 Healthcare 6.42%
5 Industrials 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCT
4326
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$1.33M ﹤0.01%
15,933
+8,225
+107% +$680K
DHT icon
4327
DHT Holdings
DHT
$3.17B
$1.33M ﹤0.01%
203,357
-740,472
-78% -$4.29M
POWW icon
4328
Outdoor Holding Co
POWW
$253M
$1.33M ﹤0.01%
+215,998
New +$1.56M
COHR icon
4329
Coherent
COHR
$54.7B
$1.33M ﹤0.01%
22,361
-42,694
-66% -$2.79M
FSTR icon
4330
Foster
FSTR
$393M
$1.32M ﹤0.01%
85,548
-47,720
-36% -$816K
IEF icon
4331
iShares 7-10 Year Treasury Bond ETF
IEF
$42.9B
$1.32M ﹤0.01%
11,500
-131,044
-92% -$15.3M
LITS
4332
Lite Strategy Inc
LITS
$33.4M
$1.32M ﹤0.01%
24,001
-6,260
-21% -$345K
FSFG
4333
DELISTED
First Savings Financial Group
FSFG
$1.32M ﹤0.01%
47,002
-32,789
-41% -$872K
MLAB icon
4334
Mesa Laboratories
MLAB
$722M
$1.32M ﹤0.01%
4,359
-3,004
-41% -$854K
UBX
4335
DELISTED
Unity Biotechnology
UBX
$1.32M ﹤0.01%
43,931
-16,673
-28% -$588K
EVOJ
4336
DELISTED
Evo Acquisition Corp. Class A Common Stock
EVOJ
$1.32M ﹤0.01%
135,832
+70,609
+108% +$685K
LGO
4337
Largo
LGO
$75.3M
$1.31M ﹤0.01%
+125,141
New +$1.76M
SGFY
4338
PUT
DELISTED
Signify Health, Inc.
SGFY
$1.31M ﹤0.01%
+73,400
New +$1.89M
OSTR
4339
DELISTED
Oyster Enterprises Acquisition Corp. Class A Common Stock
OSTR
$1.31M ﹤0.01%
134,449
+97,220
+261% +$942K
NXRT
4340
NexPoint Residential Trust
NXRT
$602M
$1.31M ﹤0.01%
21,176
+1,675
+9% +$102K
PTRAW
4341
CALL
DELISTED
Proterra Inc. Warrant
PTRAW
$1.31M ﹤0.01%
500,000
AXDX
4342
DELISTED
Accelerate Diagnostics
AXDX
$1.31M ﹤0.01%
22,458
+17,978
+401% +$1.17M
CNMD icon
4343
CALL
CONMED
CNMD
$1.5B
$1.31M ﹤0.01%
+10,000
New +$1.31M
ECH icon
4344
iShares MSCI Chile ETF
ECH
$1.05B
$1.31M ﹤0.01%
50,318
-19,513
-28% -$534K
VERX icon
4345
Vertex
VERX
$2.31B
$1.31M ﹤0.01%
67,949
+54,506
+405% +$1.05M
AXNX
4346
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.31M ﹤0.01%
20,064
-1,042,062
-98% -$71.1M
JATT.U
4347
DELISTED
JATT Acquisition Corp Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant
JATT.U
$1.3M ﹤0.01%
+130,000
New +$1.3M
BSBR icon
4348
Santander
BSBR
$43.5B
$1.3M ﹤0.01%
207,933
+3,481
+2% +$25.1K
MOLN
4349
Molecular Partners
MOLN
$172M
$1.3M ﹤0.01%
66,030
-2,115
-3% -$41.6K
JAQCU
4350
DELISTED
Jupiter Acquisition Corporation Units
JAQCU
$1.3M ﹤0.01%
+132,500
New +$1.3M

Similar funds

Israel Englander's Q3 2021 Portfolio in Review

As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

  • Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
  • Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.